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Computed Fractional Flow ReserveKyung-Hee Kim, MD,* Joon-Hyung Doh, MD,y Bon-Kwon Koo, MD,* James K. Min, MD,z
Andrejs Erglis, MD,x Han-Mo Yang, MD,* Kyung-Woo Park, MD,* Hae-Young Lee, MD,*
Hyun-Jae Kang, MD,* Yong-Jin Kim, MD,* Sung Yun Lee, MD,y Hyo-Soo Kim, MD*
Seoul and Goyang, Republic of Korea; Los Angeles, California; and Riga, LatviaObjectives This study sought to determine whether computational modeling can be used to predict
the functional outcome of coronary stenting by virtual stenting of ischemia-causing stenoses identiﬁed
on the pre-treatment model.
Background Computed tomography (CT)-derived fractional ﬂow reserve (FFR) is a novel noninvasive
technology that can provide computed (FFRCT) using standard coronary CT angiography protocols.
Methods We prospectively enrolled 44 patients (48 lesions) who had coronary CT angiography before
angiography and stenting, and invasively measured FFR before and after stenting. FFRCT was computed
in blinded fashion using coronary CT angiography and computational ﬂuid dynamics before and after
virtual coronary stenting. Virtual stenting was performed bymodiﬁcation of the computational model to
restore the area of the target lesion according to the proximal and distal reference areas.
Results Before intervention, invasive FFR was 0.70  0.14 and noninvasive FFRCT was 0.70  0.15. FFR
after stenting and FFRCT after virtual stenting were 0.90  0.05 and 0.88  0.05, respectively (R ¼ 0.55,
p < 0.001). The mean difference between FFRCT and FFR was 0.006 for pre-intervention (95% limit of
agreement: –0.27 to 0.28) and 0.024 for post-intervention (95% limit of agreement: –0.08 to 0.13).
Diagnostic accuracy of FFRCT to predict ischemia (FFR 0.8) prior to stenting was 77% (sensitivity:
85.3%, speciﬁcity: 57.1%, positive predictive value: 83%, and negative predictive value: 62%) and after
stenting was 96% (sensitivity: 100%, speciﬁcity: 96% positive predictive value: 50%, and negative
predictive value: 100%).
Conclusions Virtual coronary stenting of CT-derived computational models is feasible, and this novel
noninvasive technology may be useful in predicting functional outcome after coronary stenting.
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73Revascularization of coronary artery stenoses that induce
ischemia can improve the functional status and clinical out-
come of patients with coronary artery disease (1,2). Mea-
surement of fractional ﬂow reserve (FFR) during invasive
coronary angiography is the gold standard for the diagnosis of
ischemia-causing stenoses and can enhance clinical decision
making and reduce healthcare costs (3,4). Coronary computed
tomographic angiography (cCTA) is a commonly used
noninvasive test that can provide accurate anatomical infor-
mation on coronary artery disease (5,6). Previous studies,
however, have shown that stenosis severity interpreted on
cCTA does not match well with functional severity evaluated
by invasive FFR (7).See page 79
Abbreviations
and Acronyms
cCTA = coronary computed
tomographic angiography
FFR = fractional ﬂow reserve
FFRCT = computed fractional
ﬂow reserve from coronary
computed tomographic
angiography
LAD = left anterior
descending
TIMI = Thrombolysis In
Myocardial InfarctionRecently, application of computational ﬂuid dynamics
technology to cCTA images has enabled computation
of coronary artery blood ﬂow and pressure, and calculation
of lesion-speciﬁc FFR without the need for an invasive
procedure (8). FFR can be computed from typically acquired
cCTA scans without any additional image acquisition,
modiﬁcation of cCTA protocols, or administration of
medications. Previous studies (9,10) suggest that compu-
tation of FFR from cCTA (FFRCT) can identify patients
with functionally signiﬁcant coronary lesions prior to
invasive cardiac catheterization. The same computational
modeling technology allows for modiﬁcation of the coronary
ﬂow model to eliminate an ischemia-causing stenosis, thus
enabling “virtual stenting” of a coronary lesion. The resulting
re-calculation of coronary blood ﬂow and FFRCT can, in
turn, serve to predict hemodynamic effect of coronary
stenting in a lesion-speciﬁc manner. Such prediction of
revascularization beneﬁt (or lack thereof) may be a useful
tool for patient or lesion selection and treatment planning
prior to invasive procedures.
The purpose of this study is to determine whether virtual
stenting of coronary stenoses identiﬁed on CT-based com-
putational models can predict functional status of coronary
lesions after stenting using measured FFR as the reference
standard.
Methods
Study design and population. At 3 centers, 44 patients who
had functionally signiﬁcant coronary stenoses (35 men, mean
age 65 years) with available pre-intervention cCTA and pre-
and post-intervention FFR were enrolled. All patients were
stable adults 18 years with suspected or known coronary
artery disease who had undergone cCTA, were identiﬁed as
having a50% stenosis in a major coronary artery (2.0 mm
diameter), and who underwent clinically indicated invasive
coronary angiography with FFR measurement. Coronary
calcium scoring was not performed at the time of cCTA,although no patient was excluded based on the upper
threshold of qualitative coronary calciﬁcation, heart rate, or
body mass index. Performance and timing of the invasive
coronary angiography or FFR was at the discretion of the
treating physician, but study cases were limited to those in
which cCTA and invasive angiography was performed
within 45 days without an intervening coronary event. The
study protocol was approved by the institutional review
boards of each participating center and all patients gave
written informed consent.
cCTA and invasive coronary procedures. Each center per-
formed cCTA in accordance with the Society of Cardiovas-
cular Computed Tomography guidelines on performance of
cCTA using a variety of different CT scanner platforms
(Lightspeed VCT, GE Healthcare, Milwaukee, Wisconsin;
SomatomSensation andDeﬁnitionCT, Siemens, Forchheim,
Germany; Brilliance 256 and 64, Philips, Surrey, United
Kingdom; Aquilion One and 64, Toshiba, Otawara, Japan).
cCTA were performed by retrospective electrocardiographic
helical or prospective electro-
cardiography-triggered methods.
Oral metoprolol was administered
for any patient with a heart
rate 65 beats/min. Immediately
before image acquisition, 0.2 mg
sublingual nitroglycerin was
administered. During the cCTA
acquisition, 80 to 140 cc of
iodinated contrast was injected
followed by a 50-cc saline ﬂush.
Contrast timing was performed
to optimize uniform contrast
enhancement of the coronary
arteries. The scan parameters were
as follows: 64/256/320  0.5/0.625/0.750 mm collimation;
tube voltage 100 or 120 mV; effective 400 to 650 mA. Dose
reduction strategiesdincluding electrocardiogram-gated tube
currentmodulation and reduced tube voltagedwere employed
whenever feasible.
Coronary angiography and percutaneous coronary inter-
vention were performed by standard techniques. The
revascularization strategy, including the size of balloon and
coronary stent, was left to the discretion of the operators.
FFR was measured using a 0.014-inch pressure-monitoring
guidewire (Pressure Wire Certus, St. Jude Medical Systems,
Uppsala, Sweden) with the pressure sensor at the same
location before and after coronary stenting. Maximal
hyperemia was induced with a continuous intravenous
infusion of adenosine at the rate of 140 mg/kg/min. FFR was
calculated as the ratio of the mean distal pressure to the
mean aortic pressure during maximal hyperemia. An FFR
0.8 was considered diagnostic of lesion-speciﬁc ischemia.
FFR was measured in a blinded fashion, without knowledge
of FFRCT values.
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74FFRCT and virtual stenting. FFRCT computation was per-
formed without knowledge of pre- or post-stent FFR values
by HeartFlow, Inc. (Redwood City, California) as described
previously (9). To illustrate brieﬂy, 3-dimensional models of
the coronary tree were reconstructed using custom methods
applied to cCTA data, and coronary ﬂow and pressure were
simulated using computational ﬂuid dynamics principles (8).
Resting ﬂow was estimated from the myocardial mass, and
resting microcirculatory resistance was distributed according
to the size of the feeding vessel. A lumped parameter model
representing the resistance to ﬂow during simulated maximal
hyperemia was applied to each coronary branch of the cCTA
model, and FFRCT was computed for the entire coronary
tree. The point on the model that corresponded to the
location of the measured FFR was then selected and results
were recorded. The pre-stent computational model was then
marked with the location of the stent used to treat the
patient. Analysts, blinded as to the results of treatment and to
all FFR measurements, then performed virtual coronary
intervention by modifying the computational model in the
region of the stent to enlarge the lumen of the treated
coronary segment according to the proximal and distal
reference areas. Computational analysis of hyperemic coro-
nary ﬂow and pressure for the entire heart model was then
repeated to determine post-treatment FFRCT. A core lab
scientist, blinded to the results of measured FFR, then
selected the point on the computational model that matched
the location of post-stent FFR measurement to determineFigure 1. Invasive and Noninvasive Functional Assessment Before and After Rev
(A) Noninvasive fractional ﬂow reserve (FFR) from coronary computed tomographic an
0.72. Invasive coronary angiography and FFR conﬁrmed the functionally signiﬁcant LA
with a computed value of 0.86. Invasive FFR after stent implantation was 0.90.the corresponding FFRCT value beyond that stenosis
(Fig. 1).
Statistical analyses. Categorical data are expressed as
the number and percentage, whereas continuous variables are
presented as the mean  SD. Mean values were compared
using paired and unpaired Student t tests as appropriate.
Spearman rank correlation was used to assess the relationship
between FFR and FFRCT. The Bland-Altman analysis and
intraclass correlation coefﬁcient were used to assess the
degree of agreement between FFR and FFRCT. Statistical
analyses were performed using SPSS for Windows (version
17, SPSS Inc., Chicago, Illinois).
Results
Clinical, angiographic, and procedural characteristics. The
median time between cCTA and invasive coronary angiog-
raphy was 12 days (range: 2 to 40). Table 1 provides the
clinical, angiographic, and procedural characteristics of the
44 patients. Mean left ventricular ejection fraction was
63.1  7.4%, and 5 patients (10%) had a history of previous
myocardial infarctions. The target vessels in patients with
previous myocardial infarction were non-infarct-related
vessels. Forty-eight coronary lesions were stented; mean
stent diameter was 3.1  0.4 mm and mean stent length was
26.0  10.1 mm. All treated patients had TIMI (Throm-
bolysis In Myocardial Infarction) ﬂow grade 3 after stenting.
After stenting, angiographic percentage of diameter stenosisascularization
giography data (FFRCT) of the left anterior descending (LAD) coronary artery was
D stenosis. (B) FFRCT demonstrated no ischemia in the LAD after virtual stenting,
Table 1. Clinical, Angiographic, and Procedural Characteristics
Age, yrs 65.0  9.1
Male 35 (80)
Body mass index, kg/m2 24.4  2.6
Diabetes 13 (29)
Hypertension 36 (81)
Hyperlipidemia 28 (63)
Previous myocardial infarction 5 (10)
LV ejection fraction 63.1  7.4
Lesion locations
Left anterior descending artery 35 (73)
Left circumﬂex artery 5 (10)
Right coronary artery 8 (17)
Quantitative coronary angiography
Before stenting
Reference diameter, mm 2.96  0.68
Minimal lumen diameter, mm 1.07  0.51
Percentage of diameter stenosis 64.5  14.1
Lesion length, mm 21.5  13.5
After stenting
Reference diameter, mm 2.96  0.45
Minimal lumen diameter, mm 2.64  0.49
Percentage of diameter stenosis 10.1  8.5
Stent length, mm 26.0  10.1
Stent diameter, mm 3.1  0.42
Values are mean  SD or n (%).
LV ¼ left ventricular.
Figure 2. Correlations of FFR and FFRCT Before and After
Coronary Intervention
A good correlations (R ¼ 0.60 before stenting and R ¼ 0.55 after stenting) are
observed before and after coronary intervention. Abbreviations as in Figure 1.
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75improved to 10.1  8.5% from a pre-stent diameter stenosis
of 64.5  14.1%.
Comparison of FFRCT and invasively measured FFR. Meas-
ured FFR prior to intervention was 0.70 0.14 and increased
to 0.90  0.05 after stenting. Computed FFRCT prior to
intervention was 0.70  0.15 and increased to 0.88  0.05
after virtual coronary stenting. Therewas a positive correlation
between FFR and FFRCT before (R ¼ 0.60, p < 0.001) and
after intervention (R ¼ 0.55, p < 0.001) (Fig. 2). The mean
difference between FFRCT and FFR was 0.006 for pre-
intervention (95% limit of agreement: –0.27 to 0.28) and
0.024 for post-intervention (95% limit of agreement: –0.08
to 0.13) (Fig. 3). Intraclass correlation coefﬁcient was 0.71
(p < 0.001).
FFRCT for the prediction of residual ischemia. Residual
ischemia after stenting was found in 2 patients by FFR and
predicted in 4 patients by FFRCT. In the 2 patients with
false positives, FFR was 0.88 and FFRCT was 0.79 in 1
patient, and FFR was 0.84 and FFRCT was 0.80 in the other
patient. Diagnostic accuracy of FFRCT to predict ischemia
(FFR 0.8) prior to stenting was 77% (sensitivity: 85.3%,
speciﬁcity: 57.1%, positive predictive value: 83%, and
negative predictive value: 62%) and after stenting was 96%
(sensitivity: 100%, speciﬁcity: 96%, positive predictive value:
50%, and negative predictive value: 100%) (Fig. 4).Figure 5 illustrates the potential of this novel technology.
In one case (Fig. 5A), the operator needed to decide whether
to implant a stent from the distal left main segment to cover
fully the ostium of the left anterior descending (LAD)
coronary artery to relieve the ischemia. A stent was
implanted without covering the LAD ostium, and invasively
measured FFR after stenting was 0.74. Consistent with this
ﬁnding, FFRCT after virtual stenting without covering the
LAD ostial lesion was 0.76, which was improved to 0.81
after virtual treatment of the whole LAD lesion including
the ostium. In another case (Fig. 5B), understanding the
functional signiﬁcance of the left circumﬂex ostial lesion is
critical in planning the treatment strategy. Although the
lesion was signiﬁcant by both angiography and cCTA,
FFRCT after virtual stenting of the distal left circumﬂex
lesion was 0.83. During the invasive procedure, it was found
that the ischemia was relieved by stenting the distal lesion
with a post-stent FFR of 0.88.
Discussion
This study demonstrates that computational modeling of the
coronary tree using cCTA images and virtual stenting is
feasible and can help to predict the functional outcomes of
stenting prior to invasive coronary angiography. This novel
technique provides a noninvasive method for planning
optimal treatment strategies in a patient- and lesion-speciﬁc
manner before invasive procedures. These resultsdthough
needing validation in a larger cohortdrepresent initial ﬁndings
Figure 3. Bland-Altman Plot for the Agreement Between FFRCT and FFR Before and After Stenting
The mean difference between FFRCT and FFR is 0.006 for pre-intervention (95% limit of agreement: 0.27 to 0.28) and 0.024 for post-intervention (95% limit of
agreement: 0.08 to 0.13). Abbreviations as in Figure 1.
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76that demonstrate the potential of this technology to not only
diagnose lesion-speciﬁc ischemia but also to predict the ther-
apeutic beneﬁt of coronary revascularization.
Whereas cCTA can be helpful in identifying patients
with coronary stenosis and selecting patients for invasive
angiography, it is well known that the functional signiﬁ-
cance of stenosis cannot be accurately assessed by cCTAFigure 4. Diagnostic Performance of FFRCT After Virtual Stenting to
Predict the Presence of Ischemia After Stenting
Diagnostic accuracy of FFRCT to predict ischemia prior to stenting is 77% and
after stenting is 96%. Abbreviations as in Figure 1.(7,11–13). In the present study, we sought to assess the
accuracy of treatment planning using the computational
model to simulate a virtual stent and to determine whether
computation of anticipated post-stent FFRCT could predict
the success of stenting prior to the invasive procedures. It is
important to note that virtual stenting is performed by
modiﬁcation of the computational model derived from the
original cCTA taken before the invasive procedure, and that
post-stent FFR can be predicted from this same model
without any additional noninvasive or invasive procedures.
We found that FFRCT had a diagnostic accuracy of 96%
in predicting or ruling out myocardial ischemia after stenting
as deﬁned by a post-stent FFR of >0.80. The mean
difference between FFR after stenting and FFRCT after
virtual stenting was 0.02  0.05. Thus, it appears that
comprehensive planning of a revascularization strategy and
selection of the optimal target coronary lesion(s) for revas-
cularization is possible using this novel technology, which
can provide both anatomical and functional information
for each lesion before the invasive procedure. This technique
can be especially helpful for determining the revasculariza-
tion strategy in patients with complex disease. For example,
in patients with serial stenoses, even using invasive FFR, the
true functional signiﬁcance of each stenosis cannot be
precisely assessed until the elimination of the other stenoses
(14,15). However, it is possible to discriminate the
functional signiﬁcance of each stenosis using virtual stenting
and computed FFRCT. Therefore, clinical application of
this noninvasive “all-in-one” diagnostic and treatment
planning approach may reduce clinically unnecessary inter-
ventions, procedural time, radiation dose, and costs.
Importantly, we did not examine the potential diagnostic
performance of FFRCT to identify lesions that may be best
treated by medical therapy and/or coronary artery bypass
Figure 5. Cases Illustrating the Potential of Noninvasive Treatment Planning Using Virtual Stenting and FFRCT
(A) Post-stenting FFR was 0.74, as the ostial lesion (red arrowhead) of LAD was not covered. Intravascular ultrasound showed the uncovered plaque at the ostium of
LAD (upper right). FFRCT without covering the LAD ostial lesion was 0.76, but it was 0.81 after treating the whole LAD lesion. (B) Post-stent FFR in the left circumﬂex
(LCX) artery was 0.88 despite an angiographically signiﬁcant stenosis at the ostium of LCX. As part of pre-procedural planning prior to an invasive procedure, functional
signiﬁcance of the ostial lesion could be assessed via FFRCT after virtual stenting of distal LCX lesion (post-virtual stenting FFRCT 0.83). Abbreviations as in Figure 1.
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77graft. Whereas the FFRCT is hypothetically capable of
determination of these ﬁndings, it remains unknown
whether FFRCT can determine post-medical therapy and/or
post–coronary artery bypass graft FFR with as high a diag-
nostic performance as reported in this study of percutaneous
revascularization. Future diagnostic and outcomes studies
evaluating these concepts now appear warranted.
Study limitations. First, the number of patients enrolled in
this study was relatively small, with no systematic derivation/
validation cohorts. Future studies doing so will be needed to
corroborate these initial study results and, until then, these
ﬁndings should be considered as “proof-of-concept.” Second,
because this technology depends on the image quality of
cCTA, it can be applied only to patients with diagnostic
quality cCTA images obtained prior to invasive catheteriza-
tion. Third, as this technology does not incorporate the
microvascular injury during percutaneous coronary interven-
tion, the accuracy of post-stent FFRCT can be lower in
patients with severe microvascular injury during stent im-
plantation. Fourth, as the FFR calculation is based on resting
coronary anatomy, possible anatomical changes during actual
stress cannot be reﬂected. However, to minimize this inﬂu-
ence, all patients were given sublingual nitroglycerin imme-
diately before cCTA. Finally, FFRCT is a new technology and
further studies are needed to determine its clinical utility.
Nonetheless, this novel technique is promising, and thepresent study demonstrates its potential as a noninvasive
method for treatment planning prior to invasive coronary
angiography and interventional procedures.
Conclusions
Treatment planning using noninvasive FFRCT and virtual
stenting is feasible and may be helpful in determining optimal
revascularization strategies before invasive procedures.
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